An interim analysis from a long-term open-label extension study has underlined the clinical efficacy and safety of ...

Explore innovative nutritional and microbial strategies for effectively treating acne, alopecia, and atopic dermatitis.

Upadacitinib, a drug used to treat atopic dermatitis (AD), may potentially induce alopecia areata, a case study suggests.

Treatment with the Janus kinase (JAK) inhibitor upadacitinib (Rinvoq) showed a favorable long-term benefit-risk profile ...

Eczema affects millions of Americans, and any number of environmental and health factors can trigger flare-ups. What should ...

Individuals who suffer from atopic dermatitis are three times more likely to develop anxiety, depression and sleep ...

It is time to set the record straight and uncover the truth as Atopic Dermatitis is not just a skin issue; it can impact ...

Take short showers. Long, hot showers and baths dry out the skin, Dr. Craiglow said. Use lukewarm water, and limit bathing to ...

Key drugs from Johnson & Johnson and Eli Lilly stand to bolster their respective cases in competitive dermatology markets ...

The ADapt study assessed the efficacy and safety of EBGLYSS in individuals who had previously been treated with dupilumab.

Researchers at the Icahn School of Medicine at Mount Sinai have discovered a way that ovarian cancer tumors manipulate their environment to resist immunotherapy and identified a drug target that could ...

Researchers recently identified five extrapulmonary treatable traits in asthma that are clinically relevant and have a clear ...